Something to note: oral treatment & if successful:
https://www.google.com.au/amp/s/www.nytimes.com/2021/10/17/health/covid-treatment-access-molnupiravir.amp.html
3% vaccination rate across Africa, quoted in this article. That’s appalling. Oral treatments for COVID-19 should know no boundaries. They don’t need cold-chain nor expense or expertise to hospitals administering IV expensive MABS. Other Drug companies (ie Merck) will allow out-licensing with cheaper cost to Govts/patients for oral antivirals +/- WHO support.
https://www.reuters.com/business/healthcare-pharmaceuticals/aurobindo-pharma-stop-molnupiravir-trial-moderate-covid-19-patients-2021-10-08/
Interesting article above on Molnupiravir trials in India.
GLTAH![]()
- Forums
- ASX - By Stock
- DXB
- DXB Chart
DXB Chart, page-118
-
-
- There are more pages in this discussion • 921 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
55.0¢ |
Change
-0.060(9.84%) |
Mkt cap ! $302.3M |
Open | High | Low | Value | Volume |
60.5¢ | 61.0¢ | 55.0¢ | $2.309M | 4.010M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 137019 | 55.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.5¢ | 22500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 137019 | 0.550 |
6 | 75210 | 0.545 |
9 | 187733 | 0.540 |
3 | 46869 | 0.535 |
6 | 173766 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.555 | 22500 | 1 |
0.560 | 21428 | 1 |
0.565 | 45284 | 3 |
0.570 | 29674 | 1 |
0.575 | 39942 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online